SK3752002A3 - Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction - Google Patents
Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction Download PDFInfo
- Publication number
- SK3752002A3 SK3752002A3 SK375-2002A SK3752002A SK3752002A3 SK 3752002 A3 SK3752002 A3 SK 3752002A3 SK 3752002 A SK3752002 A SK 3752002A SK 3752002 A3 SK3752002 A3 SK 3752002A3
- Authority
- SK
- Slovakia
- Prior art keywords
- lhrh antagonist
- antagonist
- short
- treatment
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15547899P | 1999-09-23 | 1999-09-23 | |
PCT/EP2000/009212 WO2001021194A2 (en) | 1999-09-23 | 2000-09-20 | Method for the therapeutic management of endometriosis and fallopian tube obstruction |
Publications (1)
Publication Number | Publication Date |
---|---|
SK3752002A3 true SK3752002A3 (en) | 2003-06-03 |
Family
ID=22555601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK375-2002A SK3752002A3 (en) | 1999-09-23 | 2000-09-20 | Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1214086A2 (ja) |
JP (2) | JP2003509467A (ja) |
KR (1) | KR100772852B1 (ja) |
CN (2) | CN1376070A (ja) |
AU (1) | AU769482B2 (ja) |
BG (1) | BG66128B1 (ja) |
BR (1) | BR0014198A (ja) |
CA (1) | CA2383510A1 (ja) |
HK (1) | HK1049117A1 (ja) |
HU (1) | HUP0202741A3 (ja) |
IL (1) | IL148185A0 (ja) |
MX (1) | MXPA02002436A (ja) |
NO (1) | NO331198B1 (ja) |
NZ (1) | NZ534836A (ja) |
PL (1) | PL201898B1 (ja) |
RU (1) | RU2255759C2 (ja) |
SK (1) | SK3752002A3 (ja) |
TR (1) | TR200200738T2 (ja) |
TW (1) | TWI267373B (ja) |
UA (1) | UA73956C2 (ja) |
WO (1) | WO2001021194A2 (ja) |
ZA (1) | ZA200201374B (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10157628A1 (de) * | 2001-11-26 | 2003-06-12 | Zentaris Ag | Injektionslösung eines LHRH-Antagonisten |
US7214662B2 (en) | 2001-11-27 | 2007-05-08 | Zentaris Gmbh | Injectable solution of an LHRH antagonist |
KR101749310B1 (ko) | 2008-01-24 | 2017-06-21 | 에스퍼란스 파마슈티컬스, 인코포레이티드 | 용해 도메인 융합 구성물 및 이를 제조하고 사용하는 방법 |
CA2750582A1 (en) * | 2009-01-22 | 2010-07-29 | Maatschap Interne Geneeskunde Rijnstate | Method for the prophylaxis or treatment of flushing |
DK2914633T3 (da) | 2012-10-30 | 2022-03-14 | Esperance Pharmaceuticals Inc | Antistof/lægemiddel-konjugater og anvendelsesfremgangsmåder |
JP6159870B2 (ja) | 2013-03-15 | 2017-07-05 | アッヴィ・インコーポレイテッド | 月経出血過多および子宮類線維腫の処置に使用するための組成物 |
CN112261942A (zh) | 2018-04-19 | 2021-01-22 | 艾伯维公司 | 治疗重度月经出血的方法 |
EP3560555A1 (en) * | 2018-04-26 | 2019-10-30 | LifeArc | A composition for treating one or more estrogen related diseases |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5064939A (en) * | 1990-02-06 | 1991-11-12 | The Salk Institute For Biological Studies | Cyclic gnrh antagonists |
SE9301606D0 (sv) * | 1993-05-07 | 1993-05-07 | Per-Christer Oden | Composition for the treatment of impaired hair growth |
CN1137722C (zh) * | 1994-07-22 | 2004-02-11 | 汉普顿路医学院 | 为长期治疗方案确立基础(tonic)卵巢雌激素分泌 |
US5658884A (en) * | 1994-07-22 | 1997-08-19 | The Medical College Of Hampton Roads | Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
DE19513662A1 (de) * | 1995-04-08 | 1996-10-10 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
DE19604231A1 (de) * | 1996-01-29 | 1997-07-31 | Schering Ag | Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen |
CN1228708A (zh) * | 1996-09-04 | 1999-09-15 | 有限会社多特 | 经口给药用含肽药物组合物 |
CA2292605A1 (en) * | 1997-06-05 | 1998-12-10 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
DE19911771B4 (de) * | 1999-03-17 | 2006-03-30 | Zentaris Gmbh | LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung |
-
2000
- 2000-09-20 NZ NZ534836A patent/NZ534836A/en not_active IP Right Cessation
- 2000-09-20 MX MXPA02002436A patent/MXPA02002436A/es active IP Right Grant
- 2000-09-20 SK SK375-2002A patent/SK3752002A3/sk not_active Application Discontinuation
- 2000-09-20 KR KR1020027003740A patent/KR100772852B1/ko not_active IP Right Cessation
- 2000-09-20 PL PL353244A patent/PL201898B1/pl not_active IP Right Cessation
- 2000-09-20 CN CN00813196A patent/CN1376070A/zh active Pending
- 2000-09-20 JP JP2001524618A patent/JP2003509467A/ja not_active Withdrawn
- 2000-09-20 WO PCT/EP2000/009212 patent/WO2001021194A2/en active IP Right Grant
- 2000-09-20 BR BR0014198-4A patent/BR0014198A/pt not_active Application Discontinuation
- 2000-09-20 HU HU0202741A patent/HUP0202741A3/hu unknown
- 2000-09-20 RU RU2002111000/14A patent/RU2255759C2/ru not_active IP Right Cessation
- 2000-09-20 CN CNA2007100789192A patent/CN101045155A/zh active Pending
- 2000-09-20 AU AU77792/00A patent/AU769482B2/en not_active Ceased
- 2000-09-20 TR TR2002/00738T patent/TR200200738T2/xx unknown
- 2000-09-20 UA UA2002043346A patent/UA73956C2/uk unknown
- 2000-09-20 EP EP00967722A patent/EP1214086A2/en not_active Withdrawn
- 2000-09-20 IL IL14818500A patent/IL148185A0/xx not_active IP Right Cessation
- 2000-09-20 CA CA002383510A patent/CA2383510A1/en not_active Abandoned
- 2000-09-22 TW TW089119671A patent/TWI267373B/zh not_active IP Right Cessation
-
2002
- 2002-02-19 ZA ZA200201374A patent/ZA200201374B/en unknown
- 2002-03-21 NO NO20021430A patent/NO331198B1/no not_active IP Right Cessation
- 2002-04-05 BG BG106584A patent/BG66128B1/bg unknown
-
2003
- 2003-02-18 HK HK03101215.4A patent/HK1049117A1/zh unknown
-
2011
- 2011-10-17 JP JP2011227603A patent/JP2012051920A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
RU2255759C2 (ru) | 2005-07-10 |
NO20021430L (no) | 2002-05-07 |
AU769482B2 (en) | 2004-01-29 |
HUP0202741A2 (hu) | 2003-01-28 |
TR200200738T2 (tr) | 2002-08-21 |
NZ534836A (en) | 2007-07-27 |
MXPA02002436A (es) | 2003-02-12 |
IL148185A0 (en) | 2002-09-12 |
JP2012051920A (ja) | 2012-03-15 |
BG66128B1 (bg) | 2011-06-30 |
BG106584A (bg) | 2003-02-28 |
JP2003509467A (ja) | 2003-03-11 |
TWI267373B (en) | 2006-12-01 |
KR20020035879A (ko) | 2002-05-15 |
NO20021430D0 (no) | 2002-03-21 |
HK1049117A1 (zh) | 2003-05-02 |
BR0014198A (pt) | 2002-05-21 |
PL353244A1 (en) | 2003-11-03 |
HUP0202741A3 (en) | 2003-12-29 |
CN101045155A (zh) | 2007-10-03 |
UA73956C2 (en) | 2005-10-17 |
EP1214086A2 (en) | 2002-06-19 |
AU7779200A (en) | 2001-04-24 |
KR100772852B1 (ko) | 2007-11-02 |
NO331198B1 (no) | 2011-10-31 |
PL201898B1 (pl) | 2009-05-29 |
WO2001021194A2 (en) | 2001-03-29 |
CN1376070A (zh) | 2002-10-23 |
WO2001021194A3 (en) | 2002-03-14 |
ZA200201374B (en) | 2002-10-30 |
CA2383510A1 (en) | 2001-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20120015917A1 (en) | Use of Estrogenic Compounds in Combination with Progestogenic Compounds in Hormone-Replacement Therapy | |
KR100370908B1 (ko) | 기능부전성자궁출혈치료용약제의제조에유용한프로게스테론길항제 | |
Erkkola et al. | Role of progestins in contraception | |
JP2012051920A (ja) | 子宮内膜組織の子宮外の増殖、慢性骨盤痛およびファロピウス管閉塞症を治療するための製剤学的組成物、前述の疾病を治療するための医薬を製造するためのlhrhアンタゴニスト又はlhrhアンタゴニストおよび活性剤の使用 | |
JP5543920B2 (ja) | 閉経前の女性におけるエストロゲン依存症状の治療 | |
Cheng et al. | Medical treatment for uterine myomas | |
US7666836B2 (en) | Method for the therapeutic management of endometriosis | |
JP2012077020A (ja) | ゲスターゲンとGnRHアンタゴニストとの組合せ医薬 | |
KR100864547B1 (ko) | 양성 호르몬 의존성 부인과 질병의 치료 및 예방을 위한메조프로게스틴 (프로게스테론 수용체 조절물질) | |
JP3925688B2 (ja) | GnRHa治療中および/またはGnRHa治療後の副作用を治療するための製薬学的調剤 | |
BR112020021565A2 (pt) | Composição para tratamento de uma ou mais doenças relacionadas com estrogênio | |
Patel | Response of the Uterus to Medication: Hysteroscopic Implications | |
Swahn et al. | Various uses of mifepristone in gynaecology and obstetrics | |
Patel | 6 Hysteroscopic Implications | |
US20020002153A1 (en) | Pharmaceutical preparations for treating side effects during and/or after gnrha therapy | |
Bromer et al. | Medical treatment options for leiomyomas | |
Prentice et al. | Medical management of endometriosis pain | |
Patel et al. | Overview of Medical Management of Endometriosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC9A | Refused patent application |